[{"NetIncomeLoss_1_Q1_USD":-66448000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":160011000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":100524000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":947000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":34000.0,"EquitySecuritiesFvNiCost_0_Q1_USD":273257000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":30877000.0,"Depreciation_1_Q1_USD":525000.0,"IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_1_Q1_USD":-1477000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":200000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":8275000.0,"AssetsCurrent_0_Q1_USD":673984000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":111661000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":2185000.0,"PaymentsToAcquireAvailableForSaleSecurities_1_Q1_USD":127864000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":20297000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":8506000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":159817000.0,"EquitySecuritiesFvNi_0_Q1_USD":273281000.0,"CommonStockSharesIssued_0_Q1_shares":160172235.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":7731000.0,"Assets_0_Q1_USD":755173000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-2000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"ShareBasedCompensation_1_Q1_USD":13184000.0,"OperatingLeaseLiability_0_Q1_USD":66663000.0,"GainLossOnInvestments_1_Q1_USD":145000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":56973000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":82222000.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":2821000.0,"PrepaidExpenseCurrent_0_Q1_USD":28515000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":2761000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":145000.0,"AccountsReceivableNetCurrent_0_Q1_USD":56832000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":21000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_0_Q1_USD":700000.0,"CommonStockValue_0_Q1_USD":16000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q1_USD":10000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q1_Security":15.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":7726000.0,"CostsAndExpenses_1_Q1_USD":173326000.0,"IncreaseDecreaseInInventories_1_Q1_USD":492000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-66450000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":356000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":370000.0,"OtherAssetsNoncurrent_0_Q1_USD":1813000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":304487000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":60581000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":2633710000.0,"Liabilities_0_Q1_USD":173567000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-6000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":4071000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":63111000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":7726000.0,"CommonStockSharesOutstanding_0_Q1_shares":160172235.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_1_Q1_USD":45000.0,"RestrictedCashNoncurrent_0_Q1_USD":5770000.0,"InvestmentsFairValueDisclosure_0_Q1_USD":576951000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue_0_Q1_USD":97422000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-66427000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":4000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-60149000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":1633000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":8739000.0,"LiabilitiesCurrent_0_Q1_USD":109373000.0,"AccountsPayableCurrent_0_Q1_USD":8849000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1_Q1_USD":5000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":3039000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":738000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.044,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-10000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":10000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_0_Q1_USD":97422000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":310257000.0,"OperatingLeasePayments_1_Q1_USD":1014000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":9757000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":8585000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-21541000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":-1567000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"InterestReceivableCurrent_0_Q1_USD":558000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":15559000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":8355000.0,"CommonStockSharesAuthorized_0_Q1_shares":225000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":106554000.0,"OperatingIncomeLoss_1_Q1_USD":-66772000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":273281000.0,"InventoryNet_0_Q1_USD":10311000.0,"PreferredStockValue_0_Q1_USD":null,"OperatingLeaseCost_1_Q1_USD":2378000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":755173000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":21767000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":13184000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":6082000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":17417000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.42,"ProfitLoss_1_Q1_USD":-66448000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":3613000.0,"StockholdersEquity_0_Q1_USD":581606000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":1076000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-689000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-2052154000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":18370000.0,"Ticker":"ACAD","CIK":"1070494","name":"ACADIA PHARMACEUTICALS INC","OfficialName":"ACADIA Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3501345407.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]